Storage and handling
Other information store at room temperature
Other information store at room temperature
Active Ingredient
Menthol 5%
Purpose
Topical Analgesic
Uses
Temporarily relieves minor pain associated with:
Warnings
When using this product
Stop use and ask a doctor if
Keep out of reach of children.
If swallowed, get medical help or contact a Poison Control Center right away.
Directions
adults and children 12 years of age and older
Children under 12 years of age consult a doctor
Other information
Inactive ingredients
aloe barbadensis leaf juice, alumina magnesium metasilicate, aluminum hydroxide, BHT, castor oil, disodium EDTA, gelatin, glycerin, isopropyl myristate, kaolin, methylparaben, PEG-4 stearate, polysorbate 80, polyvinyl alcohol, purified water, PVP, sodium polyacrylate, tartaric acid, titanium dioxide, tocopherol acetate
Questions or comments?
1-800-WALGREENS (1-800-925-4733)
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| f52be47f-7aa7-46c0-b1fa-50c18dd50206 | Product name | 1 | 20201029 |
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 0363-0152-01 | 2020-01-31 | C162847 | 48780-1 | 9d75b9d0-afe4-f424-e053-dadaa90a57ce | Menthol 5% (Topical Analgesic) |
| 0363-0152-02 | 2020-01-31 | C162847 | 48780-1 | 9d75b9d0-afe4-f424-e053-dadaa90a57ce | Menthol 5% (Topical Analgesic) |
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 0363-0152-01 | Cool n Heat Patch for BackExtra Strength | 1 g in 1 PATCH | PATCH | 1 | 3 | |
| 0363-0152-01 | Cool n Heat Patch for BackExtra Strength | 5 in 1 BOX | PATCH | 5 | 3 | |
| 0363-0152-02 | Cool n Heat Patch for BackExtra Strength | 3 in 1 BOX | PATCH | 3 | 3 | |
| 0363-0152-02 | Cool n Heat Patch for BackExtra Strength | 1 g in 1 PATCH | PATCH | 1 | 3 |
| Ingredient | Type | UNII | SPL version | Uploaded |
|---|---|---|---|---|
| Menthol | ACTIVE INGREDIENT | L7T10EIP3A | 3 | |
| Menthol | ACTIVE MOIETY | L7T10EIP3A | 3 | |
| Aloe Vera Leaf | INACTIVE INGREDIENT | ZY81Z83H0X | 3 | |
| Alpha-Tocopherol Acetate | INACTIVE INGREDIENT | 9E8X80D2L0 | 3 | |
| Aluminum Hydroxide | INACTIVE INGREDIENT | 5QB0T2IUN0 | 3 | |
| Butylated Hydroxytoluene | INACTIVE INGREDIENT | 1P9D0Z171K | 3 | |
| Castor Oil | INACTIVE INGREDIENT | D5340Y2I9G | 3 | |
| Edetate Disodium | INACTIVE INGREDIENT | 7FLD91C86K | 3 | |
| Gelatin | INACTIVE INGREDIENT | 2G86QN327L | 3 | |
| Glycerin | INACTIVE INGREDIENT | PDC6A3C0OX | 3 | |
| Isopropyl Myristate | INACTIVE INGREDIENT | 0RE8K4LNJS | 3 | |
| Kaolin | INACTIVE INGREDIENT | 24H4NWX5CO | 3 | |
| Methylparaben | INACTIVE INGREDIENT | A2I8C7HI9T | 3 | |
| PEG-4 Stearate | INACTIVE INGREDIENT | J33E8608YN | 3 | |
| Polysorbate 80 | INACTIVE INGREDIENT | 6OZP39ZG8H | 3 | |
| Polyvinyl Alcohol | INACTIVE INGREDIENT | 532B59J990 | 3 | |
| Silodrate | INACTIVE INGREDIENT | 9T3UU8T0QK | 3 | |
| Tartaric Acid | INACTIVE INGREDIENT | W4888I119H | 3 | |
| Titanium Dioxide | INACTIVE INGREDIENT | 15FIX9V2JP | 3 | |
| Water | INACTIVE INGREDIENT | 059QF0KO0R | 3 |
Every source-derived product name is available through these pages.
| Product NDC | Package NDC |
|---|---|
| 0363-0152 | 0363-0152-01, 0363-0152-02 |
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| Menthol | L7T10EIP3A | ACTIB |
| Aloe Vera Leaf | ZY81Z83H0X | IACT |
| Aluminum Hydroxide | 5QB0T2IUN0 | IACT |
| Edetate Disodium | 7FLD91C86K | IACT |
| Gelatin | 2G86QN327L | IACT |
| Kaolin | 24H4NWX5CO | IACT |
| Methylparaben | A2I8C7HI9T | IACT |
| Glycerin | PDC6A3C0OX | IACT |
| Titanium Dioxide | 15FIX9V2JP | IACT |
| Isopropyl Myristate | 0RE8K4LNJS | IACT |
| Water | 059QF0KO0R | IACT |
| PEG-4 Stearate | J33E8608YN | IACT |
| Polyvinyl Alcohol | 532B59J990 | IACT |
| Polysorbate 80 | 6OZP39ZG8H | IACT |
| Alpha-Tocopherol Acetate | 9E8X80D2L0 | IACT |
| Silodrate | 9T3UU8T0QK | IACT |
| Castor Oil | D5340Y2I9G | IACT |
| Tartaric Acid | W4888I119H | IACT |
| Butylated Hydroxytoluene | 1P9D0Z171K | IACT |
Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.
| DailyMed ingredient | IID ingredient | UNII | Dosage form / route | Potency | Maximum daily exposure | Match |
|---|---|---|---|---|---|---|
| Isopropyl Myristate | ISOPROPYL MYRISTATE | 0RE8K4LNJS | GEL / TOPICAL | 29 mg | ||
| Edetate Disodium | EDETATE DISODIUM | 7FLD91C86K | SUSPENSION / RESPIRATORY (INHALATION) | 0.01 %w/v | ||
| Isopropyl Myristate | ISOPROPYL MYRISTATE | 0RE8K4LNJS | CREAM / TOPICAL | 65000 mg | ||
| Glycerin | GLYCERIN | PDC6A3C0OX | SOLUTION / AURICULAR (OTIC) | 63.64 %w/v | ||
| Glycerin | GLYCERIN | PDC6A3C0OX | SOLUTION / TOPICAL | 1971 mg | ||
| Methylparaben | METHYLPARABEN | A2I8C7HI9T | ENEMA / RECTAL | 0.18 %w/v | ||
| Edetate Disodium | EDETATE DISODIUM | 7FLD91C86K | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION / INTRAVENOUS | 19 mg | ||
| Glycerin | GLYCERIN | PDC6A3C0OX | SPRAY / NASAL | 22.3 mg/1ml | ||
| Glycerin | GLYCERIN | PDC6A3C0OX | SOLUTION / OPHTHALMIC | 6 %w/v | ||
| Glycerin | GLYCERIN | PDC6A3C0OX | SOLUTION / NASAL | 25 mg/1ml | ||
| Isopropyl Myristate | ISOPROPYL MYRISTATE | 0RE8K4LNJS | SUSPENSION / AURICULAR (OTIC) | 0.02 %w/w | ||
| Polysorbate 80 | POLYSORBATE 80 | 6OZP39ZG8H | SUSPENSION/ DROPS / ORAL | 23 mg | ||
| Polysorbate 80 | POLYSORBATE 80 | 6OZP39ZG8H | GRANULE, FOR SUSPENSION / ORAL | 240 mg | ||
| Butylated Hydroxytoluene | BUTYLATED HYDROXYTOLUENE | 1P9D0Z171K | CREAM / VAGINAL | 0.05 %w/w | ||
| Butylated Hydroxytoluene | BUTYLATED HYDROXYTOLUENE | 1P9D0Z171K | TABLET, ORALLY DISINTEGRATING / ORAL | 1 mg | ||
| Titanium Dioxide | TITANIUM DIOXIDE | 15FIX9V2JP | CAPSULE, LIQUID FILLED / ORAL | 12 mg | ||
| Polysorbate 80 | POLYSORBATE 80 | 6OZP39ZG8H | TABLET, ORALLY DISINTEGRATING / ORAL | 1 mg | ||
| Titanium Dioxide | TITANIUM DIOXIDE | 15FIX9V2JP | FILM / BUCCAL | 3 mg | ||
| Edetate Disodium | EDETATE DISODIUM | 7FLD91C86K | SUSPENSION / AURICULAR (OTIC) | 0.01 %w/v | ||
| Titanium Dioxide | TITANIUM DIOXIDE | 15FIX9V2JP | INSERT, EXTENDED RELEASE / OPHTHALMIC | 0.4 mg | ||
| Polysorbate 80 | POLYSORBATE 80 | 6OZP39ZG8H | CAPSULE / ORAL | 418.37 mg | ||
| Polysorbate 80 | POLYSORBATE 80 | 6OZP39ZG8H | INJECTION / INTRAVENOUS | 4680 mg | ||
| Titanium Dioxide | TITANIUM DIOXIDE | 15FIX9V2JP | TABLET, FILM COATED, EXTENDED RELEASE / ORAL | 11 mg | ||
| Polysorbate 80 | POLYSORBATE 80 | 6OZP39ZG8H | INJECTION / INTRA-ARTICULAR | 4 mg | ||
| Tartaric Acid | TARTARIC ACID | W4888I119H | SOLUTION / ORAL | 270 mg | ||
| Tartaric Acid | TARTARIC ACID | W4888I119H | TABLET / ORAL | 63 mg | ||
| Methylparaben | METHYLPARABEN | A2I8C7HI9T | DROPS / OPHTHALMIC | 0.01 %w/w | ||
| Edetate Disodium | EDETATE DISODIUM | 7FLD91C86K | TABLET, DELAYED RELEASE / ORAL | 100 mg | ||
| Isopropyl Myristate | ISOPROPYL MYRISTATE | 0RE8K4LNJS | SYSTEM / TOPICAL | 7 mg | ||
| Polysorbate 80 | POLYSORBATE 80 | 6OZP39ZG8H | TABLET, DELAYED RELEASE / ORAL | 4 mg | ||
| Edetate Disodium | EDETATE DISODIUM | 7FLD91C86K | EMULSION / TOPICAL | 0.11 %w/w | ||
| Gelatin | GELATIN | 2G86QN327L | WAFER / ORAL | NA | ||
| Butylated Hydroxytoluene | BUTYLATED HYDROXYTOLUENE | 1P9D0Z171K | SOLUTION, CONCENTRATE / ORAL | 0.1 mg/1ml | ||
| Butylated Hydroxytoluene | BUTYLATED HYDROXYTOLUENE | 1P9D0Z171K | SUPPOSITORY / VAGINAL | NA | ||
| Isopropyl Myristate | ISOPROPYL MYRISTATE | 0RE8K4LNJS | FILM, EXTENDED RELEASE / TRANSDERMAL | 20.4 mg | ||
| Methylparaben | METHYLPARABEN | A2I8C7HI9T | EMULSION / TOPICAL | 0.2 %w/w | ||
| Tartaric Acid | TARTARIC ACID | W4888I119H | INJECTION, SOLUTION / INTRAMUSCULAR | 18 mg | ||
| Edetate Disodium | EDETATE DISODIUM | 7FLD91C86K | SHAMPOO / TOPICAL | 1 %w/w | ||
| Glycerin | GLYCERIN | PDC6A3C0OX | INJECTION / INTRAVENOUS | 33750 mg | ||
| Titanium Dioxide | TITANIUM DIOXIDE | 15FIX9V2JP | TABLET, FILM COATED / ORAL | 36 mg | ||
| Methylparaben | METHYLPARABEN | A2I8C7HI9T | SYSTEM / TOPICAL | 42 mg | ||
| Methylparaben | METHYLPARABEN | A2I8C7HI9T | INJECTION, POWDER, FOR SOLUTION / INTRAVENOUS | 15 mg | ||
| Butylated Hydroxytoluene | BUTYLATED HYDROXYTOLUENE | 1P9D0Z171K | FILM, SOLUBLE / ORAL | 0.06 mg | ||
| Polysorbate 80 | POLYSORBATE 80 | 6OZP39ZG8H | CONCENTRATE / INTRAVENOUS | 4680 mg | ||
| Methylparaben | METHYLPARABEN | A2I8C7HI9T | POWDER, FOR SOLUTION / ORAL | 126 mg | ||
| Tartaric Acid | TARTARIC ACID | W4888I119H | TABLET, ORALLY DISINTEGRATING / ORAL | 45 mg | ||
| Methylparaben | METHYLPARABEN | A2I8C7HI9T | SUSPENSION / ORAL | 388 mg | ||
| Titanium Dioxide | TITANIUM DIOXIDE | 15FIX9V2JP | CAPSULE, COATED, EXTENDED RELEASE / ORAL | NA | ||
| Polysorbate 80 | POLYSORBATE 80 | 6OZP39ZG8H | INJECTION, SOLUTION / INTRAMUSCULAR | 5 %w/v | ||
| Edetate Disodium | EDETATE DISODIUM | 7FLD91C86K | DROPS / AURICULAR (OTIC) | 0.05 %w/w | ||
| Titanium Dioxide | TITANIUM DIOXIDE | 15FIX9V2JP | SOAP / TOPICAL | 1 %w/w | ||
| Polysorbate 80 | POLYSORBATE 80 | 6OZP39ZG8H | TABLET, FILM COATED / ORAL | 24 mg | ||
| Polysorbate 80 | POLYSORBATE 80 | 6OZP39ZG8H | ENEMA / RECTAL | 0.01 %w/v | ||
| Methylparaben | METHYLPARABEN | A2I8C7HI9T | SOLUTION / ORAL | 346 mg | ||
| Gelatin | GELATIN | 2G86QN327L | CAPSULE, COATED / ORAL | 288 mg | ||
| Kaolin | KAOLIN | 24H4NWX5CO | SYRUP / ORAL | 10 mg/1ml | ||
| Polysorbate 80 | POLYSORBATE 80 | 6OZP39ZG8H | SUSPENSION / SUBCUTANEOUS | 0.3 %w/v | ||
| Methylparaben | METHYLPARABEN | A2I8C7HI9T | AEROSOL, FOAM / VAGINAL | 0.1 %w/w | ||
| Edetate Disodium | EDETATE DISODIUM | 7FLD91C86K | TABLET, CHEWABLE / ORAL | 1 mg | ||
| Kaolin | KAOLIN | 24H4NWX5CO | CAPSULE, DELAYED RELEASE PELLETS / ORAL | 234 mg |
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| a9a1b401-911e-4504-a898-657326fa2c20 | 1f86a35b-a7df-4692-8c6b-cca8d7fad83e | 2013-10-15 | Warnings | a9a1b401-911e-4504-a898-657326fa2c20 1f86a35b-a7df-4692-8c6b-cca8d7fad83e |
Adverse event summaries are temporarily unavailable. Other product information remains available.